Recruiting Clinical Trials

Displaying 1 - 10 of 39 result(s)
Study Title Condition Phase Location
Study of Pharmacokinetics, Activity and Safety of Ruxolitinib in Pediatric Patients With Grade II-IV Acute Graft vs. Host Disease
  • Acute Graft Versus Host Disease
  • Phase 1
  • Phase 2
  • Country: 
    Argentina
  • Country: 
    Australia
  • Country: 
    Belgium
  • Country: 
An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study
  • Neovascular Age-related Macular Degeneration
  • Phase 4
  • Country: 
    Australia
  • Country: 
    Belgium
  • Country: 
    Czech Republic
  • Country: 
Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis
  • Colitis, Ulcerative
  • Phase 2
  • Country: 
    Bulgaria
  • Country: 
    Czech Republic
  • Country: 
    Germany
  • Country: 
Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON)
  • Age-related Macular Degeneration
  • Macular Degeneration
  • Wet Macular Degeneration
  • Retinal Degeneration
  • Retinal Diseases
  • Eye Diseases
  • Phase 3
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Australia
  • Country: 
Study of Efficacy and Safety of MBG453 in Combination With Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R, or Chronic Myelomonocytic Leukemia-2 (CMML-2)
  • Myelodysplastic Syndromes
  • Leukemia, Myelomonocytic, Chronic
  • Phase 3
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Australia
  • Country: 
An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Dimethyl Fumarate or Fingolimod to Ofatumumab
  • Relapsing Multiple Sclerosis
  • Phase 3
  • Country: 
    United States
  • Country: 
    Australia
  • Country: 
    Austria
  • Country: 
ADCC Mediated B-Cell dEpletion and BAFF-R Blockade
  • Autoimmune Hepatitis
  • Phase 2
  • Phase 3
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Belgium
  • Country: 
Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab
  • Chronic Spontaneous Urticaria
  • Phase 3
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Australia
  • Country: 
Study to Demonstrate the Efficacy, Safety and Tolerability of Intravenous Secukinumab up to 52 Weeks in Subjects With Active Psoriatic Arthritis
  • Psoriatic Arthritis
  • Phase 3
  • Country: 
    United States
  • Country: 
    Bulgaria
  • Country: 
    Czech Republic
  • Country: 
Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up
  • Liver Transplant Rejection
  • Phase 2
  • Country: 
    United States
  • Country: 
    Belgium
  • Country: 
    Czech Republic
  • Country: